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a b s t r a c t
Objective: We previously demonstrated that Sirt1 regulates apoptosis in cartilage in vitro. Here we
attempt to examine in vivo cartilage homeostasis, using Sirt1 total body knockout (KO) mice.
Method: Articular cartilage was harvested from hind paws of 1-week and 3-week-old mice carrying wild
type (WT) or null Sirt1 gene. Knees of Sirt1 haploinsufﬁcient mice also were examined, at 6 months. Joint
cartilage was processed for histologic examination or biochemical analyses of chondrocyte cultures.
Results: We found that articular cartilage tissue sections from Sirt1 KO mice up to 3 weeks of age exhibited
low levels of type 2 collagen, aggrecan, and glycosaminoglycan content. In contrast, protein levels of MMP13 were elevated in the Sirt1 KO mice, leading to a potential increase of cartilage breakdown, already
shown in the heterozygous mice. Additional results showed elevated chondrocyte apoptosis in Sirt1 KO
mice, as compared to WT controls. In addition to these observations, PTP1b (protein tyrosine phosphatase
b) was elevated in the Sirt1 KO mice, in line with previous reports.
Conclusion: The ﬁndings from this animal model demonstrated that Sirt1 KO mice presented an altered
cartilage phenotype, with an elevated apoptotic process and a potential degradative cartilage process.
Published by Elsevier Masson SAS.

1. Introduction
Osteoarthritis (OA) is a complex and multifactorial degenerative disease, leading to an imbalance between the catabolic and
anabolic factors in cartilage. Different mechanisms are involved,
such as inﬂammation, apoptosis, and breakdown of major extracellular matrix components, such as aggrecan and, type 2 collagen
under the control of matrix metalloproteases, (MMPs), such as
aggrecanases and collagenases [1]. It has been well documented
that aging is a key risk factor in OA susceptibility [2,3]. In fact,
more than 50% of adults aged 65 or more reported an arthritis diagnosis, making OA one of the most common diseases in developed
countries [4].
Sirt1 has been shown to regulate lifespan and aging in simple
eukaryotes and in rodents [2,5,6]. In mammalians, Sirt1 has been
reported to play an important role in age-related diseases such as
osteoporosis, diabetes, and cancer [6–8]. Similarly, we have previously shown in vitro that Sirt1 modulates gene expression in
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human osteoarthritic chondrocytes. Sirt1 positively regulates the
expression of extracellular matrix (ECM)-encoding genes of cartilage [9]. Further, Sirt1 enhances survival of human OA chondrocytes
by repressing apoptosis [10,11]. Recently, Sirt1 has been reported
to be involved in the pathogenesis of OA by modulating chondrocyte gene expression and hypertrophy [12]. Finally, Sirt1 plays an
anti-inﬂammatory role in different tissues by inhibiting the transcription of pro-inﬂammatory-responsive genes [6].
Despite the growing evidence supporting in vitro studies
demonstrating Sirt1’s protective role in cartilage, few studies have
establish that these roles also exist in vivo. We created Sirt1-null
mice [13,14] and found that – compared with normal mice – they
were smaller, had cranio-facial abnormalities, and their long bones
mineralized slower [15]. These observations were consistent with
the notion that Sirt1 may play a role in cartilage development and
homeostasis. Additional observations of heterozygous Sirt1 mice
(Sirt1 +/− ) showed that they exhibit increased apoptotic chondrocytes and OA severity with age, as compared to equivalent WT mice
[16].
In this study, we investigated articular cartilage of mice lacking
the Sirt1 protein (KO mice) and report that they were predisposed to develop OA because they present characteristic features of
This article is a U.S. government work, and is not subject to copyright in the United States.
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Fig. 1. Cartilage phenotype of Sirt1 KO mice. A. Sirt1 KO on the 129/J background mice. Photograph shows a KO mouse of approximately 2/3 normal size at 1 weeks of age,
with closed eyes, obstructed fur and smaller joints compared to the WT. B. At 2 days, before skeletal staining, the Sirt1 KO has already a smaller size. C. Skeletal staining with
alizarin red/alcian blue shows disparities in cartilage on the skull, on the rib cage, at the spine and on the big joints.
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Fig. 2. Skeletal staining with alizarin red/alcian blue, details: the arrows show a reduction in cartilage volume in the KO at each location, and a complete absence of cartilage
on the calvariae. The skeletal staining shows a disorganization of the rib cages, a strong eye and joints cartilage defects.
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articular cartilage degeneration, even at a young age. Our results
showed an altered cartilage phenotype in these mice due to a higher
level of cartilage breakdown and apoptosis in the Sirt1-deﬁcient
mice.
2. Methods
2.1. Animals
Experiments were performed on Sirt1-deleted 129/J mice aged
2 days, 7 days, and 3 weeks. Sirt1 knockout mice are indicated as KO (total n = 9), and wild-type as WT (total n = 20).
Littermates were generated from matings between the Sirt1+/− animals. In complement, Sirt1+/− animals were also examined at 6
months for histopathology and scored by the OA OARSI grading.
Genomic DNA from mice tail fragments was used for genotyping using the Extract-N-Amp Tissue PCR kit (Sigma, St Louis, MI).
PCR primer sequences designed to amplify the native Sirt1 and
the deleted Sirt1 were (Forward) 5 -TTCACATTGCATGTGTGTGTG3 for both and (Reverse) 5 -TAGCCTGCGTAGTGTTGGTG-3 , and
5 -ATTTGGTAGGGACCCAAAGG-3 , respectively. All animals were
housed at Taconic, Maryland, under standard conditions of temperature, light, food and water. All procedures were performed in
accordance with NIH Committees for Animal Use and Care (ARAC)
guidelines.
2.2. Primary mouse cell culture, cell count, and ﬂow cytometry
Isolation of costal cartilage from KO, or WT 7-day-old mice,
and chondrocytes plating were adapted from Gabay et al. [17].
Brieﬂy, pieces of costal cartilage were incubated in collagenase
3 mg/mL for 1 h 30 min at 37 ◦ C, carefully isolated from soft tissue
in PBS, incubated in collagenase 0.5 mg/mL overnight. Chondrocytes were washed, centrifuged and plated for a 7–10 day period
wherein they were allowed to propagate. Passages 0 and 1 chondrocytes were used for experiments because cartilage marker genes

maintained expression. Monolayer cultures were maintained in
culture conditions, as previously described [17], and growth
medium was replaced every 3 days. Prior to analysis, cells were
rinsed with PBS, trypsinized with Trypsin 0.25%, resuspended in
10 ml of growth medium, and counted with a hemocytometer using
trypan blue exclusion assay.
For analyses of cell death via ﬂow cytometry, the cells were
rinsed once in chilled PBS, trypsinized, then resuspended in 10 ml of
Dulbecco’s modiﬁed Eagle’s medium supplemented with 10% fetal
bovine serum. The cells were pelleted and resuspended in 100%
methanol. Cells were kept on ice for 10 min, pelleted, and treated
with RNase A (180 g; Sigma, St Louis, MI) for 30 min at room temperature. Propidium iodide (Sigma, St Louis, MI) was added to a
ﬁnal concentration of 75 mg/ml. Cell cycle analysis was performed
on a Coulter Proﬁle 2 ﬂow cytometer.
2.3. Protein extraction and immunoblotting
Whole-cell protein extracts were carried out according to DvirGinzberg et al., 2008 [9]. The protein extracts were resolved
by sodium dodecyl sulfate–polyacrylamide gel electrophoresis
(10 g protein/lane) and transferred onto PVDF membranes for
immunoblotting. The blots were processed as previously described
and probed with antibodies. Blots were developed using an alkaline phosphatase-conjugated secondary antibody and developed
with BCIP/nitroblue tetrazolium solution (Invitogen, Camarillo,
CA). Antibodies were purchased from Abcam (Cambridge, MA) for
PTP1b, MMP-13 and beta-actin, and Upstate/Millipore (Temecula,
CA) for Sirt1.
2.4. Histology and immunohistochemistry
For immunohistochemical analysis, cartilage samples were
ﬁxed in 4% paraformaldehyde for 24 to 48 hours, dehydrated
in a graded series of ethanol baths, embedded in parafﬁn, and
cut into 5-m sections. Slides were rehydrated and incubated

Fig. 3. Articular cartilage from Sirt1 KO shows less aggrecan, type 2 collagen and glycosaminoglycan content than their WT littermates. The paws from each genotype were
processed for immunohistochemistry for either aggrecan, type 2 collagen, or alcian blue staining at 1 week. As shown in Fig. 3, alcian blue, aggrecan and type 2 collagen
staining intensity were abrogated in the Sirt1 KO at 1 week of age by 60%, 52% and 21% respectively (magniﬁcation ×10).
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with mouse anti-Aggrecan, mouse-anti-Type II Collagen (Millipore, Temecula, CA), mouse-anti-PTP1b (Abcam, Cambridge,
MA), or mouse anti-matrix metalloprotease- (anti–MMP-13,1,-3,ADAMTS-4,ADAMTS-5) Abcam, Cambridge, MA) speciﬁc
antibodies and visualized using a broad-spectrum immunohistochemistry kit (DAB, diaminobenzidine, Invitrogen, Camarillo,
CA).
To test the presence of glycosaminoglycans, sections were
stained with alcian blue and with safranin-O/light green to examine
subchondral bone and OA. Joints of the paws and the knees were
examined for 1 week and 3 week-old mice.
Cartilage defects at 6 months in the +/– were assessed in
accordance with the OsteoArthritis Research Society International
(OARSI) histopathology initiative-recommendations for histological assessment of OA in mice [18].
Total skeletal coloration was performed with basic ethanolKOH:glycerol alizarin red-alcian blue, according to Depew [19].
Results were analyzed using the Color Atlas of Fetal Skeleton of
the mouse, rat and rabbit [20].
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2.5. Statistical analysis
Means and standard deviations were calculated. Statistical analysis was performed using one-way analysis of variance, assuming
conﬁdence levels of ≤ 95% (P ≤ 0.05) to be statistically signiﬁcant.
Error bars represent the standard deviation around the mean value
of each data point. An asterisk (*) was used to denote statistically
signiﬁcant differences between controls and experimental conditions. The immunoblots represent two repetitions of three different
experiments (n = 6). For IHC, the mean of positive stain cells was
determined; stained cells reﬂected a greater than 10-fold intensity above the background, determined by scanning densitometry
(Image J software). A scoring method adapted from Lee et al., [21]
was used well to determine the coloration of the tissue matrix. An
average of three ﬁelds from three sections of each separate genotype (–/–, ++) of three different animals were assessed. Each ﬁeld
was blindly read by two different readers. Cartilage defects were
scored in accordance with the OARSI histopathology initiative OA
scoring for mice [18].

Fig. 4. Elevated protein levels of MMP-13 in Sirt1 KO cartilage at 3 weeks. The paws of 3-week-old mice were processed for immunohistochemistry for MMP-13, and
counterstained with hematoxylin (magniﬁcation ×10 upper panel and ×20 lower panel). The percent positively stained cells per ﬁeld were determined for an average of
six ﬁelds from three sections of three separate mice of each genotype (graph below immunosections). The error bars in all graphs indicate the standard deviation and the
statistical signiﬁcance is indicated by an asterisk, * . P < 0.001 (=1.7189E-5).
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3. Results
3.1. Sirt1 KO mice exhibited defects in the cartilage of the skull,
spine, rib cages, and joints, consistent with their reduced size
Examination of the two strains shows a reduced size for the
Sirt1 KO mice, as compared to the wild types, at 2, 7 days and 3
weeks. Some exterior defects are also evident, such as closed eyes
and bad fur at 1 week (Fig. 1). At 2 days, the mice already exhibit a
difference in size (Fig. 1B). Skeletal staining at 2 days on the Sirt-1
KO and Sirt1 Wild type mice (Fig. 1C), conﬁrmed that Sirt1 KO mice
exhibit a smaller size, cranio-facial and eye defects compared to
their littermate, in line with previous reports [13,15].
We further examined the effect on the skeleton and cartilage
on the same mice (Fig. 2). Sirt1 KO mice exhibited less cartilage
in the skull, rib cage, spine and in knee joints, due to their size.
They all exhibited less bone mineralization which implies defects in
cartilage hypertrophy attributing to delayed skeletal development.
Interestingly, the sutures of the calvariae were not ﬁxed in the KO,
compared with the WT mice (arrows). These observations were
similar in all KO analyzed, as compared with the WT mates (n = 3
each).
3.2. Articular cartilage tissue from Sirt1 KO exhibited low levels of
type 2 Collagen, Aggrecan and Glycosaminoglycan (GAG) content
in the paws, and a high level of MMP-13
The superﬁcial zone from articular cartilage of distal interphalangian joints of the posterior paws, were examined. Alcian blue
coloration was carried out to visualize glycosaminoglycan (GAG)

content, which are hallmarks of healthy cartilage. Results, illustrated in Fig. 3, showed less GAG content in KO paws as compared
to WT. To further assess levels of aggrecan and type 2 Collagen,
immunohistochemistry for cartilage was carried out and quantiﬁed using densitometry and statistical analysis. Overall, the paws
showed a decrease in alcian blue intensity, aggrecan, and type 2
collagen in the KO (60%, 52%, and 21%, respectively) as compared
to WT mice at 1 week of age.
To determine whether the catalytic enzymes involved in cartilage degeneration were elevated in the KO mice, we performed
immunohistochemistry for matrix metalloproteinase (MMP) -13,
aggrecanase, which have been documented to be elevated in OA
[22]. As shown in Fig. 4, this MMP is increased in the cartilage of
the KO mice, compared with their littermates. Immunostaining for
MMP-1, MMP-3, ADAMTS-4, and -5 was similar between KO and
WT at 3 weeks of age (data not shown).
Because KnockOut mice die in early age, additional analyses and
scoring were carried out in accordance with the OARSI initiative OA
scoring for adult mice in the heterozygous mice (Fig. 5) The Sirt1+/−
mice presented elevated cartilage degeneration at 6 months, with
a total mean score of 3.9, corresponding to moderate OA relative to
their WT littermates which possessed a score of 1.25 corresponding
to early-stage OA.
3.3. Enhanced apoptosis in cartilage of Sirt1 KO compared to WT
mice; PTP1b is elevated in Sirt1 KO mice cartilage compared with
WT mice
Mice chondrocytes from each genotype were cultured and
counted daily. Whereas WT chondrocytes grew normally,

Fig. 5. Elevated cartilage breakdown in older Sirt1 heterozygous mice. Knee sections of 6-month-old WT and Sirt1 heterozygous mice were processed for coloration with
safranin-O/Light green. Examination of 36 sections from 6 months mice knees showed signiﬁcant higher cartilage degradation in the Sirt1 heterozygous as compared with
their littermates (magniﬁcation ×16). The pictures are representative of the whole analysis. At 6 months, the mean of the cartilage degradation grade, adapted from the OARSI
semi-quantitative scoring for OA severity (here, grade 0 = no degradation, grade 5 = denuded cartilage surface with sclerotic bone) showed 3.9 for the Sirt1 heterozygous and
1.2 for the WT (P < 0.001). The scoring of 12 samples for each genotype (two sections of two different knees from three different mice from each genotype) showed more
severe grades for the Sirt1 heterozygous knees.
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Fig. 6. Increased apoptotic process in Sirt1 KO vs. WT. A. Two different genotypes chondrocytes were plated at 500,000 cells/plate. Student T-test compared the WT and KO
(48 h: P = 5.285 E-09, P < 0.0001; 72 h: P = 6.122 E-07, P < 0.0001; 96 h: P = 3.0066 E-07, P < 0.0001; 7 days: P = 2.5 E-05, P < 0.0001 respectively). B. Flow cytometry was carried
out for apoptotic cells using the propidium iodide method. The graph represents the apoptotic cells percentage found after 48 h or 4 days of culture. WT and KO exhibited
signiﬁcant differences at 48 h and 4D (P = 8.08 E-06, P < 0.0001 et P = 6.99 E-05, P < 0.0001 respectively). C. Protein extracts from KO and WT genotypes were immunoblotted
for PTP1b antibody. The graph represents the ratio PTP1b/beta-actin, by image J scanning densitometry (P < 0.001). The error bars in all graphs indicate the standard deviation,
and the statistical signiﬁcance as indicated by an asterisk, * .

articular chondrocytes derived from the Sirt1 KO mice did not propagate in culture (Fig. 6A). FACS analyses indicated elevated numbers
of apoptotic cells in cultures of KO chondrocytes at 2 and 4 days
(Fig. 6B). This data supports that Sirt1 contributes to chondrocyte
proliferation and lack of it could lead to limited growth and development of cartilage.
As previously published by Gagarina et al. in 2010, Sirt1 may
prevent chondrocyte apoptosis in a protein tyrosine phosphatase b
(PTP1b)-dependent manner. To examine PTP1b expression in vivo,
immunoblot analyses were carried out. Immunoblot analyses of
proteins derived from the different genotypes conﬁrmed that
PTP1b was elevated in Sirt1 KO mice compared with WT controls
(Fig. 6C), further supporting the enhanced levels of apoptotic chondrocytes in KO mice.
4. Discussion
Recent publications show that the protein deacetylase Sirt1
plays an important role in cartilage biology and homeostasis
[9,10,15,23,24]. Our current study demonstrates that mice lacking
Sirt1 protein possess an altered cartilage phenotype, in line with
our previous reports in 9 month Sirt1 haploinsufﬁcient mice [16].
Further, we describe two different phenomena underlying this phenotype: an increase in chondrocyte apoptosis and an accelerated
articular cartilage breakdown showing a regulation of cartilage by
Sirt1 in vivo.
The Sirt1-null mice were smaller in size compared to WT mice
in equivalent ages, which agrees with previous reports [13,14,25].
We also found obvious defects on the skin that could beneﬁt further
investigation. These mice suffer high perinatal mortality, particularly when carried on an inbred mouse strain. Indeed, in vitro

analyses showed that chondrocytes isolated from pups surviving 7
days after birth, did not attach properly, frequently apoptosed, and
were found ﬂoating in culture growth media. Here we conclude
that much of the age-related cartilage phenotype is attributed to
Sirt1protein.
We also compared histologic data for the WT and Sirt1 heterozygous strains at 6 months presented Fig. 5, because the KO mice
were not alive at this age. As seen in the pictures, heterozygous
mice possess a signiﬁcant enhancement in OA severity and cartilage
degradation as compared to WT mice at 6 months.
We previously showed that Sirt1 enhances the survival of
human osteoarthritic chondrocytes by repressing protein tyrosine
phosphatase 1b and activating the insulin-like growth factor receptor pathway [10,15]. Consistent reports show that using Sirtuin
inhibitors for Sirt1 and Sirt2 induced cell death through p53 hyperacetylated [26]. Accordingly, and in line with our current report,
altering Sirt1 levels could lead to enhanced cell death via multiple mechanisms and diminish the protective effect Sir11 holds on
chondrocyte viability in vivo.
Very few studies have demonstrated the role of Sirt1 in vivo with
regards to cartilage biology or age-induced arthritis. As mentioned,
our recent publication comparing WT and haploinsufﬁcient Sirt1
mice compared musculoskeletal features, OA severity scoring, and
apoptosis in cartilage of 1-month-old and 9-month-old mice [16].
The results showed a signiﬁcant decrease in Sirt1 protein levels in
the heterozygous mice compared with their littermates at 1 month.
Interestingly, both strains ceased to express full-length Sirt1 at 9
months.
Sirt1 KO mice showed an accelerated cartilage degenerative
process and early onset OA features. Accumulation of matrix metalloproteinases in the cartilage and low levels of type 2 collagen
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and aggrecan could predict very weak mechanical properties of
cartilage in these mice, making them susceptible to cartilage degeneration. Our study showed increased MMP-13, aggrecanase, with
reduced ECM content in the KO mice at 3 weeks of age. However, it
is not yet clear if the decreased intensity of aggrecan, type 2 collagen
and GAG content in our experiments is due to the decrease of the
cellularity within cartilage tissues of KO mice. These data suggest
early OA onset exists in KO mice. While MMP-13 levels are elevated
in Sirt1 KO mice, other aggrecanases did show a similar increase in
these mice strains. It appears that collagen type 2 breakdown and
MMP-13 were most affected and correlated well with OA severity
in Sirt1 in vivo mice model used herein.
The present communication further accentuates that Sirt1 is
necessary for the normal development of articular cartilage in vivo.
In its absence, even at a young age, mice develop cartilage degeneration and early-onset OA, which is normally developed with
advanced age.
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